As summarized in Table 1, PLXND1 is abundantly expressed in both the vasculature and malignant cells in the majority of clinical tumors, whereas in pre-malignant lesions the protein is present at lower levels or, like in non-tumor related tissues, almost completely absent (Table 2). The gene discussed is PLXND1; the disease is neoplasm.